Mecasermin is made by Tercica Pharmaceuticals (Increlex) as a treatment for 'short stature' due to severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone. Mecasermin is also known as rhIGF-1
provided by;
Clinicaltrials.gov search results for 'mecasermin'
NLM (Pubmed) search results for 'mecasermin'
Tercica - Increlex (mecasermin [rDNA origin] for injection - "rhIGF-1")
Big Pharmaceutical Companies - caveat emptor!